Oscar Arrieta
Instituto Nacional de Cancerología de México · Instituto Nacional de Cancerologia, Mexico · Instituto Nacional de Cancerologia de Mexico
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Oscar Arrieta as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:10 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05267496 · Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest SurgeryInstituto Nacional de Cancerologia de Mexico · active not recruiting · Lung Cancer, Mediastinal Tumor, Pleural Tumor · principal investigator
- Ph2NCT03803787 · Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer PatientsInstituto Nacional de Cancerologia de Mexico · recruiting · Radiation Pneumonitis · principal investigator
- N/ANCT03071705 · Metformin Plus TKI Use in Patients With Non-Small Cell Lung CarcinomaInstituto Nacional de Cancerologia de Mexico · unknown · Non-Small Cell Adenocarcinoma, Tyrosine Kinase Mutation, EGFR Gene Mutation · study director
- N/ANCT02978521 · Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer PatientsInstituto Nacional de Cancerologia de Mexico · recruiting · Pulmonary Rehabilitation, Sarcopenia, Quality of Life · study director
- N/ANCT02805530 · Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung CarcinomaInstituto Nacional de Cancerologia de Mexico · completed · Carcinoma, Non-Small-Cell Lung, Synchronous Neoplasms · principal investigator
- Ph2/Ph3NCT02802540 · Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer PatientsInstituto Nacional de Cancerologia de Mexico · unknown · Non-Small Cell Lung Cancer, Anorexia, Cachexia · principal investigator
- N/ANCT02734069 · Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLCInstituto Nacional de Cancerologia de Mexico · recruiting · Lung Cancer, Sarcopenia, Toxicity · principal investigator
- Ph2NCT01894633 · Study of Whole-brain Irradiation With Chloroquine for Brain MetastasesInstituto Nacional de Cancerologia de Mexico · terminated · Brain Metastasis · principal investigator
- Ph2NCT01880515 · Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)Instituto Nacional de Cancerologia de Mexico · completed · Skin Rash, Lung Cancer · principal investigator
- Ph2NCT01869023 · Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural MesotheliomaInstituto Nacional de Cancerologia de Mexico · unknown · Advanced Malignant Pleural Mesothelioma · principal investigator
- N/ANCT01662635 · Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)Instituto Nacional de Cancerologia de Mexico · completed · Non Small-cell Lung Cancer · principal investigator
- N/ANCT01580579 · Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With ChemoradiationInstituto Nacional de Cancerologia de Mexico · completed · Radiation; Adverse Effect, Pneumonitis · principal investigator
- Ph2NCT01542437 · Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung CancerInstituto Nacional de Cancerologia de Mexico · completed · Non-Small Cell Lung Cancer, EGFR, HER-2 · principal investigator
- Ph2NCT01337154 · First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung CancerCytRx · terminated · Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion, Stage IV Non-small Cell Lung Cancer · principal investigator
- N/ANCT01052818 · Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung CancerNational Institute of Cancerología · unknown · Circulating Tumor Cells · principal investigator
- Ph2/Ph3NCT01048970 · Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung CancerNational Institute of Cancerología · unknown · Lung Cancer · principal investigator
- Ph2NCT01048645 · Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung CancerNational Institute of Cancerología · completed · Non-Small-Cell Lung Carcinoma · principal investigator
- N/ANCT01023828 · K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic ImplicationsNational Institute of Cancerología · completed · Non-Small Cell Lung Cancer · principal investigator
- N/ANCT00862173 · Gene-expression Profiles in CNS-metastatic Non-small Cell Lung CancerNational Institute of Cancerología · unknown · Brain Disease, Metastasis, Lung Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:10 UTC. The ranking covers the 200 most relevant of 40 PubMed records, and a shared surname and initials can bring in a namesake. All 40 on PubMed
- 7,991 citationsRCR 252.7
- 1,074 citationsRCR 29.0
- 732 citationsRCR 21.9
- Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.J Clin Oncol · 2021568 citationsRCR 28.4
- Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial.J Clin Oncol · 2011248 citationsRCR 5.9
- A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.Ann Oncol · 2007213 citationsRCR 4.3
- Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study.Haematologica · 2017190 citationsRCR 8.0
- 180 citationsRCR 6.7
- 140 citationsRCR 5.2
- 122 citationsRCR 2.6